Ignite Creation Date:
2024-05-06 @ 12:41 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01633060
Status:
TERMINATED
Last Update Posted:
2019-01-30
First Post:
2012-06-29
Brief Title:
A Phase III Study of BKM120 With Fulvestrant in Patients With HRHER2- AI Treated Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CBKM120F2303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None